Abstract

AbstractThe effects of the organophosphorus insecticide terbufos on laboratory‐reared and wild northern bobwhites (Colinus virginianus) were investigated in laboratory dosing studies and dose‐release field trials. Laboratory studies yielded a terbufos LD50 of 24.4 mg/kg‐body weight (bw). All mortalities occurred within the first 24 h post‐dose. Wild bobwhites were trapped, administered 0, 3, 5.6, or 21 mg/kg‐bw terbufos by oral intubation, released at their trapping site, and monitored for 14 d. Mortality, activity, and locational data were recorded. Bobwhites treated with 21 mg/kg‐bw terbufos had significantly lower survival (p = 0.04) than control birds, while survival at the lower doses was unaffected. No significant differences (p = 0.06) were detected in physical activity among treatments. The 21‐mg/kg‐bw dose yields an anticipated 37% mortality (or LD37) when interpolated from the LD50 slope equation. After adjustment for control mortality, the 21‐mg/kg‐bw dose led to 44% mortality in wild bobwhites. This was a 7% higher mortality than predicted by interpolation from the laboratory generated LD50. These results indicate that there was not a substantial increase in mortality of wild bobwhites compared to laboratory‐reared bobwhites at nonlethal or lethal, sub‐LD50, doses.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call